Dieter Palmberger

Dieter Palmberger

Auto-generated profile, based on publicly available information

Dieter Palmberger

Vienna Institute of BioTechnology - VIBT, University of Natural Resources and Life Sciences, Vienna, Austria

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2010 in Molecular Biotechnology
Verified
Journal Article
Closed access
PDF file
Florian KrammerFlorian Krammer
Florian Krammer
TSTheresa Schinko
Theresa Schinko
DPDieter Palmberger
Dieter Palmberger
CTChristopher Tauer
Christopher Tauer
PMPaul Messner
Paul Messner
RGReingard Grabherr
Reingard Grabherr

2 April 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DPDieter Palmberger
Dieter Palmberger
IWIain Wilson
Iain Wilson
IBImre Berger
Imre Berger
RGReingard Grabherr
Reingard Grabherr
DRDubravko Rendic
Dubravko Rendic
Recombinant production of therapeutically active proteins has become a central focus of contemporary life science research. These proteins are often produced in mammalian cells, in order to obtain products with post-translational modifications similar to their natural counterparts. However, in cases where a fast and flexible system for recombinant production of proteins is needed, the use of mammalian cells is limited. The baculoviral insect cell system has proven to be a powerful alternative for the expression of a wide range of recombinant proteins in short time frames. The major drawback of baculoviral systems lies in the inability to perform mammalian-like glycosylation required for the production of therapeutic glycoproteins. In this study we integrated sequences encoding Caenorhabditis elegans N-acetylglucosaminyltransferase II and bovine β1,4-galactosyltransferase I into the backbone of a baculovirus genome. The thereby generated SweetBac virus was subsequently used for the production of the human HIV anti-gp41 antibody 3D6 by integrating heavy and light chain open reading frames into the SweetBac genome. The parallel expression of target genes and glycosyltransferases reduced the yield of secreted antibody. However, the overall expression rate, especially in the recently established Tnao38 cell line, was comparable to that of transient expression in mammalian cells. In order to evaluate the ability of SweetBac to generate mammalian-like N-glycan structures on 3D6 antibody, we performed SDS-PAGE and tested for the presence of terminal galactose using Riccinus communis agglutinin I. The mammalianised variants of 3D6 showed highly specific binding to the lectin, indicating proper functionality. To confirm these results, PNGase A released N-glycans were analyzed by MALDI-TOF-MS and shown to contain structures with mainly one or two terminal galactose residues. Since the presence of specific N-glycans has an impact on antibodies ability to exert different effector functions, we tested the binding to human Fc gamma receptor I present on U937 cells.

1 January 2014 in Vaccine
Verified
Journal Article
Open access
MKMiriam Klausberger
Miriam Klausberger
MWMonika Wilde
Monika Wilde
DPDieter Palmberger
Dieter Palmberger
RHRong Hai
Rong Hai
RARandy Albrecht
Randy Albrecht
Florian KrammerFlorian Krammer
Florian Krammer
Human infections with a novel influenza A H7N9 subtype virus were reported in China recently. The virus caused severe disease with high mortality rates and it raised concerns over its pandemic potential. Here, we assessed in the mouse model protective efficacy of single immunisations with low vaccine doses of insect cell-derived H7 virus-like particles, consisting of hemagglutinin and matrix protein. Vaccinated mice were fully protected and survived a stringent lethal challenge (100 mLD50) with H7N9, even after a single, unadjuvanted, low vaccine dose (0.03 μg). Serum analysis revealed broad reactivity and hemagglutination inhibition activity across a panel of divergent H7 strains. Moreover, we detected significant levels of cross-reactivity to related group 2 hemagglutinins. These data demonstrate that virus-like particle vaccines have the potential to induce broadly protective immunity against the novel H7N9 virus and a variety of other H7 strains.

29 December 2013 in Biotechnology Letters
Verified
Journal Article
Open access
PDF file
MWMonika Wilde
Monika Wilde
MKMiriam Klausberger
Miriam Klausberger
DPDieter Palmberger
Dieter Palmberger
WEWolfgang Ernst
Wolfgang Ernst
RGReingard Grabherr
Reingard Grabherr
Purpose of work: A comparative analysis of new and established insect cell lines, in regard to process relevant parameters, provide data that can be exploited for designing more robust and effective protein production processes. The baculovirus-insect cell expression system has been efficiently used for the production of heterologous proteins. Three different insect cell lines Tnao38, High Five and Sf9 were compared in terms of virus susceptibility, baculovirus production and product yield of an intra-cellularly (YFP) and extra-cellularly (influenza A virus hemagglutinin)-expressed recombinant protein. The Tnao38 and High Five cell lines exhibited higher (tenfold) susceptibility to baculovirus infection than Sf9 cells, whereas Sf9 cells showed a higher (100-fold) capacity for production of infectious virus particles. Analysis of recombinant protein expression revealed considerably higher product yields in Tnao38 and High Five cells as compared to Sf9 cells, for both model proteins. Overall, the two Trichoplusia ni-derived cell lines, High Five and Tnao38, were significantly more efficient in terms of secreting proteins such as the glycoprotein hemagglutinin of influenza A virus.

1 May 2011 in Journal of Biotechnology
Verified
Journal Article
Closed access
DPDieter Palmberger
Dieter Palmberger
DRDubravko Rendić
Dubravko Rendić
PTPhilipp Tauber
Philipp Tauber
Florian KrammerFlorian Krammer
Florian Krammer
IWIain Wilson
Iain Wilson
RGReingard Grabherr
Reingard Grabherr

12 January 2010 in Biotechnology Journal
Verified
Journal Article
Closed access
PDF file
Florian KrammerFlorian Krammer
Florian Krammer
SNSabine Nakowitsch
Sabine Nakowitsch
PMPaul Messner
Paul Messner
DPDieter Palmberger
Dieter Palmberger
BFBoris Ferko
Boris Ferko
RGReingard Grabherr
Reingard Grabherr